English | Español
Erianne Leatherman | Apr 5, 2017

BMS, Foundation Medicine partner on predictive biomarker project
Robert Hadley | Apr 5, 2017

Pharma spinoff AbbVie joins network to share oncology outcomes
Robert Hadley | Apr 5, 2017

Immunotherapy drug approved for U.S. patients
Erianne Leatherman | Apr 5, 2017

Sanofi Genzyme expands Multiple Myeloma Journey Partners program

Erianne Leatherman | Apr 3, 2017

Symproic receives approval with U.S. launch expected this summer

Ruth de Jauregui | Apr 3, 2017

European Medicines Agency recommends Keytruda for approval
Kyle Perrotti | Apr 3, 2017

New algorithm could help EMS determine best hospital for treatment of stroke
Ruth de Jauregui | Apr 3, 2017

Inebilizumab receives orphan status from EMA for optic nerve disorder treatment

Trending
Patient Daily | Nov 5, 2025

Pacific Research Institute CEO on misuse of 340B funds: ‘340B was meant to help low-income patients'
+ Pharmaceuticals
Patient Daily | Nov 6, 2025

Mark Cuban on PBMs: ‘Patients are getting ripped off because PBMs and wholesalers insist on using inflated list prices'
Patient Daily | Nov 5, 2025

Riley Gaines on 340B program: ‘Blue states are using taxpayer dollars to fund unregulated child mutilation procedures’
+ Pharmaceuticals
Patient Daily | Nov 3, 2025

Patient groups urge Congress to renew enhanced premium tax credits before open enrollment